Burden of Leprosy in Indonesia: A Comprehensive Analysis from the Global Burden of Disease Study 2021
Abstract:
Indonesia is the fourth most populous country in the world
and has the third highest burden of Leprosy after India and Brazil. Prevention
and treatment have been carried out in Indonesia by trying to improve services
and quality of Leprosy care, but the incidence of this disease is still
relatively high. This study aims to analyze the incidence, prevalence, and
total DALYs (Disability Adjusted Life Years) of Leprosy in Indonesia based on
the results of the GBD 2021(Global Burden of Disease) study. Researchers
analyzed absolute figures, rates/levels, and age-standardized figures from 1990
to 2021. In this study, researchers used GBD 2021 data to estimate the temporal
trend of the Leprosy burden in Indonesia. The analysis used three standard
epidemiological measures, namely incidence, prevalence, and disability-adjusted
life years (DALYs) by sex and age in Indonesia. The results of the analysis
showed that 1992 was the lowest year with a prevalence of 24,725 cases and 2015
was the highest year with 37,287 cases. The lowest incidence of Leprosy
occurred in 1990 with 3,018 cases and the highest incidence occurred in 2020
with 4,568 cases. The year with the lowest DALY was 1992 with 1,304 cases and
the year with the highest DALY was 2013 with 1,984 cases. The results of this
study are expected to be used as a strategy for controlling Leprosy in
Indonesia. Researchers hope that the government or health workers will carry
out early detection of prevention in high-risk communities to stop the
transmission of Leprosy and to reduce the prevalence of disability or negative
side effects that will cause stigma in society.
References:
[1] Samosir, P. M., Axelia, P. G., Alkaff, F. F.,
Salamah, S., & Alinda, M. D., 2023, Prevalence and risk factors for
disability in leprosy patients in Indonesia during the post-elimination era. Dermatology
Reports, 15, 223–229. https://doi.org/10.4081/dr.2023.9777
[2] Chen, K. H., Lin, C. Y., Su, S. Bin, &
Chen, K. T., 2022, Leprosy: A Review of Epidemiology, Clinical Diagnosis, and
Management. Journal of Tropical Medicine. https://doi.org/10.1155/2022/8652062
[3] Sugawara-Mikami, M., Tanigawa, K., Kawashima,
A., Kiriya, M., Nakamura, Y., Fujiwara, Y., & Suzuki, K., 2022.
Pathogenicity and virulence of Mycobacterium leprae. Virulence, 13(1),
1985–2011. https://doi.org/10.1080/21505594.2022.2141987
[4] Gunawan, H., & Nurani, N. B., 2024.,
Dermoscopic features of nails in Leprosy patients in a tertiary referral
hospital in West Java, Indonesia. BMC Infectious Diseases, 24(1),
1–9. https://doi.org/10.1186/s12879-024-09224-0
[5] Yunar, M. F., 2023, Mengenal Penyakit Kusta.
Kemenkes RI. https://yankes.kemkes.go.id/view_artikel/142/mengenal-kusta
[6] Dianita, R., 2020., Perbandingan Determinan
Kejadian Kusta pada Masyarakat Daerah Perkotaan dan Pedesaan. HIGEIA
(Journal of Public Health Research and Development, 4 (Special 3),
692–704, https://journal.unnes.ac.id/sju/higeia/article/view/39719
[7] Menaldi, S. L., Harini, M., Nelfidayani, N.,
Irawati, Y., Setiono, S., Wahyuni, L. K., Rahayu, T., Andayani, G., Friska, D.,
& Nugraha, B., 2022, Functional activity limitation of leprosy cases in an
endemic area in Indonesia and recommendations for integrated participation
program in society. PLoS Neglected Tropical Diseases, 16(8), 1–8.
https://doi.org/10.1371/JOURNAL.PNTD.0010646
[8] Dharmawan, Y., Korfage, I. J., Abqari, U.,
Widjanarko, B., & Richardus, J. H., 2023, Measuring leprosy case detection
delay and associated factors in Indonesia: a community-based study. BMC
Infectious Diseases, 23(1), 1–10. https://doi.org/10.1186/s12879-023-08552-x
[9] G. Minervini, R. Franco, M.M.
Marrapodi, M. Di Blasio, V. Ronsivalle, M. Cicciù., 2023, Children oral health
and parents education status: a cross-sectional study, BMC Oral Health 23 787.
https://doi.org/10.1186/s12903-023-03424-x.[10] Kavita, Thakur, J. S., & Narang, T. 2023,
The burden of skin diseases in India: Global Burden of Disease Study 2017. Indian
Journal of Dermatology, Venereology and Leprology, 89(3), 421–425. https://doi.org/10.25259/IJDVL_978_20
[11] Wahyuni, L. K., Nelfidayani, N., Harini, M.,
Anestherita, F., Wardhani, R. K., Menaldi, S. L., Irawati, Y., Rahayu, T.,
Andayani, G., Daniel, H., Savitri, I., Hariyanto, P. K. Y., & Paramita, I.
A. 2024, The International Classification of Functioning, Disability and Health
to map leprosy-related disability in rural and remote areas in Indonesia. PLoS
Neglected Tropical Diseases, 18(5), 1–27. https://doi.org/10.1371/journal.pntd.0011539
[12] Institute for Health Metrics and Evaluation
(IHME). 2022. Global Burden of Disease Study 2021 (GBD 2021) Results.
Global Burden of Disease Collaborative Network. https://vizhub.healthdata.org/gbd-results/
[13] Van’T Noordende, A. T., Lisam, S.,
Ruthindartri, P., Sadiq, A., Singh, V., Arifin, M., van Brakel, W. H., &
Korfage, I. J. 2021. Leprosy perceptions and knowledge in endemic districts in
india and indonesia: Differences and commonalities. PLoS Neglected Tropical
Diseases, 15(1), 1–19. https://doi.org/10.1371/journal.pntd.0009031
[14] Putri, A. I., de Sabbata, K., Agusni, R. I.,
Alinda, M. D., Darlong, J., de Barros, B., Walker, S. L., Zweekhorst, M. B. M.,
& Peters, R. M. H. 2022, Understanding leprosy reactions and the impact on
the lives of people affected: An exploration in two leprosy endemic countries. PLoS
Neglected Tropical Diseases, 16(6). https://doi.org/10.1371/journal.pntd.0010476
[15] Rai, S. S., Peters, R. M. H., Syurina, E. V,
Irwanto, I., Naniche, D., & Zweekhorst, M. B. M., 2020, Intersectionality
and health-related stigma: insights from experiences of people living with
stigmatized health conditions in Indonesia. International Journal for Equity
in Health, 19(1). https://doi.org/10.1186/s12939-020-01318-w
[16] Nery, J. S., Ramond, A., Pescarini, J. M.,
Alves, A., Strina, A., Ichihara, M. Y., Fernandes Penna, M. L., Smeeth, L.,
Rodrigues, L. C., Barreto, M. L., Brickley, E. B., & Penna, G. O., 2019,
Socioeconomic determinants of leprosy new case detection in the 100 Million
Brazilian Cohort: A population-based linkage study. The Lancet Global Health,
7(9), e1226–e1236. https://doi.org/10.1016/S2214-109X(19)30260-8
[17] Ariyanta, F., & Muhlisin, A. 2017, Hubungan
Antara Dukungan Keluarga Terhadap Konsep Diri Pada Penderita Kusta. Berita
Ilmu Keperawatan, 10(1), 20–27 https://journals.ums.ac.id/index.php/BIK/article/view/10233
[18] Lasso, C. K. R. 2023. Faktor Hambatan Dalam
Akses Pelayanan Kesehatan Pada Puskesmas di Indonesia: Scoping Review. Jurnal
Ilmiah Permas: Jurnal Ilmiah STIKES Kendal, 13(Oktober), 1–8 https://journal2.stikeskendal.ac.id/index.php/PSKM/article/view/991/871
[19] Prakoeswa, F. R. S., Soebono, H., Husada, D.,
Notobroto, H. B., Listiawan, M. Y., Endaryanto, A., & Prakoeswa, C. R. S.
2020, Towards prevention and eradication of leprosy: Current status and
research needed in community health & immune dysregulation. Indian
Journal of Leprosy, 92, 257–278 https://www.ijl.org.in/published-articles/03022022161826/4_Prakoeswa_Oct_Dec_2020.pdf
[20] Ramadorai, A., Ravi, P., Narayanan,V., 2019, Rhinocerebral mucormycosis: A prospective
analysis of an effective treatment protocol, Ann. Maxillofac. Surg. 9 192–196.
https://doi.org/10.4103/ams.ams_231_18.
[21] Krismawati, H., Irwanto, A., Pongtiku, A.,
Irwan, I. D., Maladan, Y., Sitanggang, Y. A., Wahyuni, T., Tanjung, R., Sun,
Y., Liu, H., Zhang, F., Oktavian, A., & Liu, J. 2020. Validation study of
hla-b* 13:01 as a biomarker of dapsone hypersensitivity syndrome in leprosy
patients in Indonesia. PLoS Neglected Tropical Diseases, 14(10),
1–11. https://doi.org/10.1371/journal.pntd.0008746
[22] Alemu Belachew, W., & Naafs, B. 2019.
Position statement: LEPROSY: Diagnosis, treatment and follow-up. Journal of
the European Academy of Dermatology and Venereology, 33(7),
1205–1213. https://doi.org/10.1111/jdv.15569
[23] Ezhilarasan, D. Lakshmi, T.M. Subha, Deepak Nallasamy. V,
Raghunandhakumar, S., 2022, The ambiguous role of sirtuins in head and neck
squamous cell carcinoma, Oral Dis. 28
559–567. https://doi.org/10.1111/odi.13798.
[24] Rathod, S. P., Jagati, A., & Chowdhary, P.
2020. Disabilities in leprosy: an open, retrospective analyses of institutional
records. Anais Brasileiros de Dermatologia, 95(1), 52–56. https://doi.org/10.1016/j.abd.2019.07.001
[25] Sari, A. A., & Rahmawati, R. 2023. A
Bibliometric Analysis of Aloe vera in Wound Healing. Pharmacon: Jurnal
Farmasi Indonesia, 20(1), 36–49. https://doi.org/10.23917/pharmacon.v20i1.22312
[26] Prakoeswa, C. R. S., Lubis, R. S., Anum, Q., Argentina, F., Menaldi, S. L., Gunawan, H., Yuniati, R., Mulianto, N. R., Siswati, A. S., Widasmara, D., Rusyati, L. M. M., Mamuaja, E. H., Muchtar, V., Agusni, R. I., Kusumaputra, B. H., Alinda, M. D., & Listiawan, M. Y., 2022, Epidemiology of Leprosy in Indonesia: A Retrospective Study. Berkala Ilmu Kesehatan Kulit Dan Kelamin, 34(1), 29–35. https://doi.org/10.20473/bikk.v34.1.2022.29-35
